• Users Online: 714
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
REVIEW
Year : 2012  |  Volume : 3  |  Issue : 1  |  Page : 4-11

Iron Balance in β-thalassemia: Maintaining an Antioxidant / Oxidant Ratio


1 The Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, Rensselear, NY, USA
2 King Abdel Aziz University, Faculty of Medicine, Hematology Department, Jeddah, Saudi Arabia

Date of Web Publication30-Jun-2014

Correspondence Address:
Shaker A Mousa
Professor of Pharmacology, Vice Provost, Executive Vice President and Chairman, Pharmaceutical Research Institute at Albany College
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions
  Abstract 

ί-Thalassemia is a genetic disorder affecting approximately 1.5% of men and women worldwide. Many affected individuals die by the age of 30 years as a result of cardiac complications caused by iron overload. Iron overload can lead to increased oxidative stress and iron deposition in vital organs such as the heart, liver, and endocrine glands. In contrast, excessive removal of iron can lead to infection and other complications. Hence, iron hemostasis is essential for the balance of the redox system. An extensive literature search was conducted using PubMed for studies on iron chelation therapy and antioxidant use in ίthalassemia. The search parameters included the period from 1997 to the present along with specific key words. The key words searched included "antioxidants", "iron chelation", and "complications in beta thalassemia". Iron overload in patients with ί-thalassemia should be managed by a combination therapy that includes iron chelation and antioxidants, to better manage thalassemia complications and optimize the benefit/risk ratio of iron chelation therapy. Adjunct therapy with antioxidants such as zinc, vitamin D, CoQ10, and vitamin E should be considered. ί-Thalassemia patients are at risk of increased oxidative stress. Antioxidants in conjunction with chelation therapy would play a key role in restoring the antioxidant / oxidant balance while maintaining iron hemostasis.

Keywords: iron balance, reactive oxygen species, oxidants, free radicals, antioxidants, iron chelation, Vitamin D, minerals, complications in beta thalassemia, thalassemia major


How to cite this article:
Patel HV, Qari M, Mousa SA. Iron Balance in β-thalassemia: Maintaining an Antioxidant / Oxidant Ratio. J Appl Hematol 2012;3:4-11

How to cite this URL:
Patel HV, Qari M, Mousa SA. Iron Balance in β-thalassemia: Maintaining an Antioxidant / Oxidant Ratio. J Appl Hematol [serial online] 2012 [cited 2019 Nov 22];3:4-11. Available from: http://www.jahjournal.org/text.asp?2012/3/1/4/135674

.




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract

 Article Access Statistics
    Viewed1286    
    Printed49    
    Emailed2    
    PDF Downloaded114    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]